期刊文献+

COX-2与结直肠癌的临床病理参数及5-FU敏感性之间的关系 被引量:6

Correlation between cyclooxygenase-2 and clinicalpathological characteristics/chemosensitivity to 5-FU in human colorectal cancer
下载PDF
导出
摘要 目的:研究COX-2与结直肠癌临床病理参数之间的关系及对化疗药作用的影响。方法:共纳入100例经病理确诊的新鲜人结直肠癌标本,5-FU的体外敏感实验通过三维微组织块培养法(HDRA)验证。采用免疫组化法检测对应结直癌组织中COX-2表达水平。结果:COX-2表达水平与肿瘤组织的分化程度呈负相关(P=0.05),与病理分期呈正相关(P=0.02),与神经侵犯呈正相关(P=0.02)。COX-2表达水平与5-FU药物敏感呈负相关(P=0.02)。结论:COX-2与结直肠癌的分期、分型有关,同时与5-FU的耐药相关。 Objective:To investigate the expression of COX -2 and its correlation with clinicalpathological charac- teristics and chemosensitivity to 5 - FU in human colorectal cancer. Methods: We collected freshly - removed colorec- tal tumor specimens from 100 patients. Chemosensitivity to 5 - FU was determined by histoculture drug response assay (HDRA). The correlation between COX -2 expression and clinicalpathological parameters were analysed. Results: The COX- 2 expression was correlated with TNM stage, neural invasion, differentiation and chemosensitivity to 5 - FU. Conclusion:The COX -2 expression level is associated with tumor metastasis and stage, and the overexpression of COX - 2 in clolorectal cancer were associated with the chemosensitivity to 5 - FU.
出处 《现代肿瘤医学》 CAS 2014年第4期869-872,共4页 Journal of Modern Oncology
基金 国家自然基金(编号:81172094) 江苏省自然基金(编号:BK2011095)
关键词 环氧化酶-2 结直肠癌 免疫组化 三维微组织块培养法 COX - 2 colorectal cancer immunohistochemistry HDRA
  • 相关文献

参考文献9

二级参考文献89

  • 1BinXiong Tao-JiaoSun Wei-DongHu Fu-LinCheng MinMao Yun-FengZhou.Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance[J].World Journal of Gastroenterology,2005,11(8):1105-1108. 被引量:15
  • 2赵东兵,高纪东,单毅,周志祥,袁兴华,吴健雄,邵永孚.结肠癌根治术后转移复发的特点及预后分析[J].中华胃肠外科杂志,2006,9(4):291-293. 被引量:36
  • 3韩杰,吕炳蓉,檀碧波,何春年,吕柏楠,赵建辉.消化道肿瘤淋巴结转移灶多药耐药性的变化及其意义[J].中华实验外科杂志,2006,23(12):1495-1496. 被引量:28
  • 4Patel VA, Dunn MJ, Sorokln A. Regulation of MDR1 (P-glyeoprotein) by cyclooxygenase-2. J Biol Chem,2002;277(41) : 38915-38920.
  • 5Ratnasinghe D, Daschner PJ, Anver MR, et al. Cyclooxygenase-2, P-glyeoprotein-170 and drug resistance, is ehemoprevention against muhidrug resistance possible? Anticancer Res,2001 .21(3C):2141-2147.
  • 6Hao Z, Li X, Qiao T, et al. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer ceils. Cancer Biol Ther, 200615 (3) : 261-266.
  • 7Wang LS, Chow KC, Wu YC, et al. Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma. Int J Cancer, 2004;111(2) :246-251.
  • 8Salvatore C, Camarda G, Maggi CA, et al. NF-kappaB activation contributes to anthraeycline resistance pathway in human ovarian carcinoma cell line A2780. Int J Oncol,2005.27 (3) : 799-806.
  • 9ZHANG F, WARSKULAT U, WETTSTEIN M, et al. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages [ J ]. Biochem J, 1995,312 (Pt1) : 135 -143.
  • 10SHENG H,SHAO J,MORROW J D,et al. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells [J]. Cancer Res, 1998,58( ): 362 - 366.

共引文献71

同被引文献83

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部